Moderna plummets 25% after cancer-vaccine data leak
FROM THE WIRE · FINANCE.YAHOO.COM
Moderna shares tumbled as reported results for its cancer vaccine with Merck circulated ahead of a planned conference presentation. Continue Reading
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe share drop reflects the early circulation of results developed with Merck.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Moderna shares tumbled as reported results for its cancer vaccine circulated.
- 02The results circulated ahead of a planned conference presentation.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Moderna, Inc.202.63 USDMarket closedtoday -17.57%Negative Merck & Co., Inc.147.24 USDMarket closedtoday -1.76%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets